Literature DB >> 7985312

Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid.

M Kriegmair1, R Baumgartner, R Knuechel, P Steinbach, A Ehsan, W Lumper, F Hofstädter, A Hofstetter.   

Abstract

OBJECTIVES: Tiny papillary tumors and flat urothelial lesions such as dysplasia or carcinoma in situ can easily be missed during routine cystoscopy. Various methods for in vivo detection of fluorescing agents (preferentially localized in malignant tissue) have been developed. Most of them are based on systemically administered synthetic porphyrin compounds and require sensitive detection devices and image processing units for fluorescence visualization. The usefulness of intracellularly accumulated endogenous protoporphyrin IX (PPIX), induced by 5-aminolevulinic acid (ALA), for diagnosis of early bladder cancer and the correlation with cystoscopic, microscopic, and fluorescence findings was investigated.
METHODS: ALA was instilled intravesically in 68 patients, followed by fluorescence cystoscopy with violet light from a krypton ion laser that produced fluorescence excitation. There were 299 biopsies obtained from fluorescing and nonfluorescing areas of the bladder.
RESULTS: ALA-induced fluorescence could be easily observed with the naked eye during cystoscopy under violet light illumination. All tumor lesions were sharply marked with brightly shining red fluorescence. Correlation of fluorescence and microscopic findings gave a sensitivity of 100% and a specificity of 68.5%. There were 26 malignant or precancerous lesions that were missed during routine cystoscopy but were detected only by ALA-induced fluorescence.
CONCLUSIONS: Labeling of urothelial lesions by PPIX fluorescence induced by intravesically instilled ALA seems to be a promising diagnostic procedure for malignant lesions that are difficult to visualize with standard cystoscopy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7985312     DOI: 10.1016/s0090-4295(94)80167-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  46 in total

Review 1.  Photodynamic therapy.

Authors:  D C Shackley; C Whitehurst; N W Clarke; C Betts; J V Moore
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

Review 2.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.

Authors:  R Bachor; E Reich; A Rück; R Hautmann
Journal:  Urol Res       Date:  1996

Review 4.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

5.  Imaging of glioma tumor with endogenous fluorescence tomography.

Authors:  Dax S Kepshire; Summer L Gibbs-Strauss; Summer L Gibbs-Struass; Julia A O'Hara; Michael Hutchins; Niculae Mincu; Frederic Leblond; Mario Khayat; Hamid Dehghani; Subhadra Srinivasan; Brian W Pogue
Journal:  J Biomed Opt       Date:  2009 May-Jun       Impact factor: 3.170

Review 6.  Enhanced Endoscopy in Bladder Cancer.

Authors:  Shane Pearce; Siamak Daneshmand
Journal:  Curr Urol Rep       Date:  2018-08-17       Impact factor: 3.092

Review 7.  [Photodynamic diagnostics of the bladder: current study results].

Authors:  A Karl; C Stief; D Zaak
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

8.  Photodynamic diagnosis for superficial bladder cancer: do all risk-groups profit equally from oncological and economic long-term results?

Authors:  Wolfgang Otto; Maximilian Burger; Hans-Martin Fritsche; Andreas Blana; Wolfgang Roessler; Ruth Knuechel; Wolf F Wieland; Stefan Denzinger
Journal:  Clin Med Oncol       Date:  2009-04-30

9.  [Photodynamic diagnostics in the urinary tract. Consensus paper of the Working Group for Oncology of the German Society for Urology].

Authors:  A Stenzl; D Jocham; P Jichlinski; K Junker; F König; H van den Bergh; B Volkmer; D Zaak; J E Gschwend
Journal:  Urologe A       Date:  2008-08       Impact factor: 0.639

10.  Value of fluorescence cystoscopy in high risk non-muscle invasive bladder cancer.

Authors:  Roman Mayr; Maximilian Burger
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.